Clinical Trial Update: Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing dasatinib to imatinib in chronic myeloid leukemia completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2010-01-07